EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
Josef S Smolen(Medical University of Vienna), Robert Landewé(Amsterdam UMC Location University of Amsterdam), Ferdinand C. Breedveld(Leiden University Medical Center), Maya H Buch(University of Leeds), Gerd Burmester(Cal Poly Humboldt), Maxime Dougados(Délégation Paris 5), Paul Emery(University of Leeds), C. Gaujoux-Viala(Université de Nîmes), Laure Gossec(Sorbonne Université), J. Nam(University of Leeds), Sofía Ramiro(Amsterdam UMC Location University of Amsterdam), Kevin Winthrop(Oregon Health & Science University), Maarten de Wit(European League Against Rheumatism), Daniel Aletaha(Medical University of Vienna), Neil Betteridge(European League Against Rheumatism), J. W. J. Bijlsma(University Medical Center Utrecht), Maarten Boers(Amsterdam UMC Location Vrije Universiteit Amsterdam), Frank Buttgereit(Cal Poly Humboldt), Bernard Combe(Université de Montpellier), Maurizio Cutolo(University of Genoa), Nemanja Damjanov(University of Belgrade), Johanna M. W. Hazes(Erasmus MC), Marios Kouloumas(European League Against Rheumatism), Tore K Kvien(Diakonhjemmet Hospital), Xavier Mariette(Université Paris-Sud), Karel Pavelká(Charles University), Piet L. C. M. van Riel(Radboud University Nijmegen), Andrea Rubbert‐Roth(University of Cologne), Marieke Voshaar(European League Against Rheumatism), David L. Scott(King's College School), Tuulikki Sokka‐Isler(Central Finland Health Care District), John B. Wong(Tufts University), Désirée van der Heijde(Leiden University Medical Center)
Cited by 1,761Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis